• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青黛膏走罐治疗寻常型银屑病瘙痒不适的护理干预研究。

Research on Nursing Intervention of Qing Dai Cream Walking Jar on Pruritic Discomfort in Patients with Common Psoriasis.

出版信息

Altern Ther Health Med. 2024 Oct;30(10):128-133.

PMID:38330554
Abstract

INTRODUCTION

Qing Dai cream is a Chinese medicine that helps relieve the symptoms of psoriasis vulgaris. However, its mechanism hasn't been illustrated well.

OBJECTIVE

To evaluate the effectiveness and comfortableness of Qing Dai cream walking jar as a nursing intervention for patients with psoriasis vulgaris.

METHODS

Seventy-six patients with vulgar psoriasis admitted to our hospital from February 2020 to February 2021 who met the criteria according to the including and exclusion criteria were screened as this study's subjects. According to the randomized number and double-blind principle, all of them were separated into 2 groups, the subjects in the control group were provided with conventional care, while the subjects in the observation group were joint Qing Dai cream walking jar on this basis. The quality of life and the degree of skin lesions of the patients after the intervention were comprehensively evaluated compared and observed.

RESULTS

Compared to the control group, the psoriasis lesion area and severity index (PASI) score after the intervention was remarkably lower in the observation group (P < .05) while the symptom scores, itching degree, itching frequency, duration, lesion area, sleep condition, and self-conscious condition degrees were significantly lower in the observation group (P < .05). The observed group showed a significant effect, effective, and the overall effective rate of 57.89% (22/38), 36.84%, and 94.74% were all significantly more than those of the control group after intervention (P < .05). After the intervention, the scores of dermatological disease quality of life index (DLQI), the subjective symptoms, daily life, work and study, and interpersonal relationships in the observation group were all significantly lower than those in the control group, P < .05. In the intervention, the satisfaction, total satisfaction of 65.79% (25/38), and 97.37% were statistically significantly higher than that of the control group, P < .05.

CONCLUSION

The Qing Dai cream walking jar is effective in improving patients' clinical symptoms, relieving their pruritus discomfort, and promoting the repair of skin lesions, to improve their quality of life and satisfaction.

摘要

简介

青黛膏是一种中药,有助于缓解寻常型银屑病的症状。然而,其机制尚未得到充分说明。

目的

评价青黛膏走罐作为寻常型银屑病患者护理干预的有效性和舒适度。

方法

筛选出 2020 年 2 月至 2021 年 2 月期间符合纳入和排除标准的 76 例寻常型银屑病患者作为研究对象。根据随机数字和双盲原则,将所有患者分为 2 组,对照组给予常规护理,观察组在此基础上联合青黛膏走罐。综合评估比较两组患者干预后的生活质量和皮损程度。

结果

与对照组相比,观察组患者干预后的银屑病皮损面积和严重程度指数(PASI)评分明显降低(P <.05),同时观察组患者的症状评分、瘙痒程度、瘙痒频率、持续时间、皮损面积、睡眠状况和自我意识状况评分均显著降低(P <.05)。观察组总有效率为 57.89%(22/38)、36.84%(14/38)和 94.74%(36/38),均明显高于对照组(P <.05),观察组观察效果显著。干预后,观察组皮肤病生活质量指数(DLQI)评分、主观症状、日常生活、工作学习和人际关系等各项评分均明显低于对照组(P <.05)。干预过程中,观察组满意度、总满意度为 65.79%(25/38)和 97.37%,均明显高于对照组(P <.05)。

结论

青黛膏走罐可有效改善患者的临床症状,缓解瘙痒不适,促进皮损修复,提高患者生活质量和满意度。

相似文献

1
Research on Nursing Intervention of Qing Dai Cream Walking Jar on Pruritic Discomfort in Patients with Common Psoriasis.青黛膏走罐治疗寻常型银屑病瘙痒不适的护理干预研究。
Altern Ther Health Med. 2024 Oct;30(10):128-133.
2
Chinese herbal Pulian ointment in treating psoriasis vulgaris of blood-heat syndrome: a multi-center, double-blind, randomized, placebo-controlled trial.中药普连膏治疗血热型寻常型银屑病的多中心、双盲、随机、安慰剂对照试验
BMC Complement Altern Med. 2017 May 15;17(1):264. doi: 10.1186/s12906-017-1631-5.
3
Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.口服中药复方PSORI-CM01联合外用序贯疗法治疗中重度寻常型银屑病:一项双盲、随机、安慰剂对照试验的初步研究
Trials. 2016 Mar 16;17(1):140. doi: 10.1186/s13063-016-1272-x.
4
Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial.瘙痒是银屑病患者的一个严重问题,也是疾病严重程度和生活质量之间的中介:一项随机对照试验的结果。
Br J Dermatol. 2014 Nov;171(5):1215-9. doi: 10.1111/bjd.13065. Epub 2014 Oct 15.
5
Effect of behavior modification combined with health belief model education on adherence to skin moisturizing care in patients with psoriasis vulgaris.行为矫正联合健康信念模式教育对寻常型银屑病患者皮肤保湿护理依从性的影响
Sci Rep. 2024 Dec 30;14(1):31997. doi: 10.1038/s41598-024-83647-2.
6
Pruritus and quality of life in moderate-to-severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study.中重度斑块状银屑病瘙痒和生活质量:来自 PRISTINE 研究的事后探索性分析。
J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1114-20. doi: 10.1111/jdv.12761. Epub 2014 Nov 5.
7
Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis.药物剂型影响生活质量:一项关于0.05%丙酸氯倍他索泡沫剂与0.05%丙酸氯倍他索乳膏和0.05%溶液联合方案治疗银屑病的随机单盲研究。
Cutis. 2003 Nov;72(5):407-11.
8
Effectiveness of flesh-moistening paste in psoriasis vulgaris patients with symptom pattern of blood stasis: a randomized and parallel-controlled trial.润燥膏治疗血瘀证寻常型银屑病患者的有效性:一项随机平行对照试验。
J Tradit Chin Med. 2020 Dec;40(6):1018-1025. doi: 10.19852/j.cnki.jtcm.2020.06.013.
9
A randomized controlled single-blind clinical trial on 84 outpatients with psoriasis vulgaris by auricular therapy combined with optimized Yinxieling Formula.一项针对 84 例寻常性银屑病患者的耳穴贴压联合优化银屑灵方的随机对照单盲临床试验。
Chin J Integr Med. 2012 Mar;18(3):186-91. doi: 10.1007/s11655-012-1020-3. Epub 2012 Apr 2.
10
An alkaloid-rich phytopharmaceutical prepared from Qing Dai against IL-17A-induced psoriasis.从青黛中提取的富含生物堿的植物药治疗白细胞介素-17A 诱导的银屑病。
J Ethnopharmacol. 2024 Jan 10;318(Pt A):116924. doi: 10.1016/j.jep.2023.116924. Epub 2023 Jul 15.